Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dermata Therapeutics Inc

0.7290
+0.01902.68%
Post-market: 0.73000.0010+0.14%18:52 EDT
Volume:44.85K
Turnover:32.03K
Market Cap:3.96M
PE:-0.09
High:0.7300
Open:0.7200
Low:0.7000
Close:0.7100
Loading ...
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Correspondence

Form CORRESP - Correspondence
Jul 08, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 02, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 30, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 28, 2023

Major Issues Report

8-K - Current report
Mar 28, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2023

Major Issues Report

8-K - Current report
Mar 16, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 16, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 16, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 15, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 14, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 14, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 13, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 13, 2023

Correspondence

CORRESP [Cover] - Correspondence